Extramural Funding

Print

The following is a list of active extramural funding opportunities, provided as a courtesy to UCLA Jonsson Comprehensive Cancer Center members. To be included on this list, funding must be unlimited or not administered directly by the JCCC.

Listings are generally updated as a batch on a monthly basis. Entries are ordered by posting date, with most recent postings first. Funding opportunities are removed from this list once their final application due date has passed.

Posted February 21, 2017

AAMDSIF Bone Marrow Research Grant 2017 Research Grant

Application Due Date(s): February 28, 2017

How to Apply: Please visit their website via this link for more information.

Description: The Aplastic Anemia and MDS International Foundation, Inc. (AAMDSIF) is pleased to help researchers dedicated to the study of bone marrow failure advance the understanding and treatment of aplastic anemia, myelodysplastic syndromes (MDS), and paroxysmal nocturnal hemoglobinuria (PNH).  For more than 20 years, the AAMDSIF has provided financial support to research that leads to new insights into the causes of the bone marrow failure and that leads to the development of new therapeutic approaches. Successful applicants can be funded up to $60,000 for two years ($30,000 each year, with second-year funding pending approved progress in the first year


American Italian Cancer Foundation 2017 International Post-Doctoral Research Fellowships

Application Due Date(s): February 28, 2017

How to Apply: Please download the application PDF via this link to apply

Description: The American-Italian Cancer Foundation's (AICF) International Post-Doctoral Research Fellowship Program provides financial support for the post-doctoral research of bright young scientists who pursue research and advanced training in collaboration with mentors at major cancer centers in the United States and Italy.

Fellowship stipends of $40,000 for the 2017 to 2018 periods are meant to cover most living expenses of the awarded candidate. The stipend excludes indirect costs that may be required by the host institution. Specifically no fringe benefits can be charged to the fellowship award. The stipend is paid to the host institution in the form of a restricted grant to the host institution to specifically reimburse the Fellow for living expenses during the award. AICF requires an expenditure report at the end of each year of the grant period.


American Italian Cancer Foundation 2017 Prize for Scientific Excellence in Medicine

Application Due Date(s): February 28, 2017

How to Apply: Please download the application PDF via this link to apply

Description: The American-Italian Cancer Foundation (AICF) invites you to nominate a candidate for the Prize for Scientific Excellence in Medicine in 2017. The Prize has been established to recognize important discoveries in cancer biology, prevention, diagnosis and/or treatment. Two awardees will be selected and each presented with a $50,000 prize at AICF’s annual Benefit Dinner & Auctions in New York. The Prize winners are then required to give a lecture on their research at a symposium which is held the day following the Benefit.


Alliance for Cancer Gene Therapy 2017 Investigator’s Award in Clinical Translation of Cell and Gene Therapies for Cancer

Application Due Date(s): March 21, 2017

How to Apply: Please visit their website via this link for more information.

Description: Alliance for Cancer Gene Therapy, Inc. (ACGT) funds research aimed at furthering the development of cell and gene therapy approaches to the treatment of cancer. To this end, ACGT offers awards in Clinical Translation of Cell and Gene Therapy for Cancer, to qualified scientists at the assistant professor level and above.

The award provides up to a maximum of $500,000 distributed over two to three years, inclusive of a maximum of 10 percent indirect costs. The funds may be used at the recipient’s discretion for salary, technical assistance, supplies, animals or capital equipment, but may not support staff not directly related to the project, e.g., secretaries or administrative assistants. Purchase of equipment is not allowed in the final year of the grant. Continued support is contingent upon submission and approval of a non-competitive renewal application each year. 


American Society of Radiation Oncology (ASTRO) 2017 Junior Faculty Career Research Training Award

Application Due Date(s): March 31, 2017

How to Apply: Please visit their website via this link for more information.

Description: The ASTRO Junior Faculty Career Research Training award aims to stimulate interest in radiation research early in junior faculty’s careers by offering them the opportunity to have focused time for research projects in radiation oncology, biology, physics or outcomes/health services.

This award provides $100,000 a year for two years. Time extensions can be requested to extend the award up to three years; the total award amount will not increase.


American Society of Radiation Oncology (ASTRO) 2017 Residents/Fellows in Radiation Oncology Research Seed Grant

Application Due Date(s): March 31, 2017

How to Apply: Please visit their website via this link for more information.

Description: The ASTRO Residents/Fellows in Radiation Oncology Research Seed Grant is designed to support residents or fellows who are planning a career focusing primarily on basic science or clinical research. It is designed for the exceptional trainee and implies dedication to a career in research.

This award provides up to $25,000 for one year. Time extensions can be requested to extend the award for and additional year (limit of two additional total years); the total award amount will not increase. No salary support is provided.


American Cancer Society 2017 Institutional Research Grant

Application Due Date(s): April 1, 2017

How to Apply: Please visit their website via this link for more information.

Description: With a primary focus on beginning investigators, the American Cancer Society’s Extramural Grants Program seeks to support innovative cancer research across a wide range of disciplines to meet critically important needs in the control of cancer. Each year, the Society receives approximately 2,000 requests for support of cancer research and for training of health care professionals. All proposals are subjected to multiple levels of rigorous and independent peer review to identify the most meritorious projects for funding.

Institutional Research Grants are awarded to institutions as block grants to provide seed money for newly independent investigators to initiate research projects. Grants are made for one to three years, and average $120,000 per year. These grants are renewable.


Elsa U. Pardee Foundation Research Grant

Application Due Date(s): April 30, 2017

How to Apply: Please visit their website via this link for more information.

Description: This grant provides funding to investigators in the U.S. that propose research directed toward identifying new treatments or cures for cancer. The Foundation particularly encourages grant applications for a one year period which will allow establishment of capabilities of new cancer researchers, or new cancer approaches by established cancer researchers. It is anticipated that this early stage funding by the Foundation may lead to subsequent and expanded support using government agency funding. Project relevance to cancer detection, treatment, or cure should be clearly identified.

There is no minimum or maximum set for the budget. However, most grants average $100,000 to $150,000 for one year. Applications requesting more than 15 percent overhead are not usually considered for funding.


Damon Runyon Cancer Research Foundation Damon Runyon-Rachleff Innovation Award

Application Due Date(s): July 6, 2017

How to Apply: Please visit their website via this link for more information.

Description: The Damon Runyon-Rachleff Innovation Award is designed to provide support for the next generation of exceptionally creative thinkers with “high-risk/high-reward” ideas that have the potential to significantly impact our understanding of and/or approaches to the prevention, diagnosis or treatment of cancer.

The Stage 1 award will be for two years, $150,000 per year ($300,000 total) with the opportunity for up to two additional years of funding (up to four years total for $600,000). Stage 2 support for years three and four will be granted to those awardees who demonstrate progress on their proposed research during years one and two of the award. Applicants will provide a written update on their research and present their progress in person to the committee shortly before the end of the second year of the award, at which time the committee will make a decision regarding continued funding.

Since the goal of the Innovation Award is to fund high risk/high reward research that lacks sufficient preliminary data to secure traditional funding, the applicant should not have funding for this proposed project. During the course of the award, award recipients are encouraged to seek additional funding to expand and further develop their projects.

Posted February 6, 2017

V Foundation 2017 Cancer Research Grant Program Translational Award

Application Due Date(s): March 1, 2017

How to Apply: Please submit a one-page statement of research project and CV to Nancy Presseau via email.

Description:  The V Foundation seeks to support translational research projects within the scope of all types of cancers. The Translational Research Award is a $600,000 grant awarded in three annual installments of $200,000. Indirect costs up to a maximum of 10 percent within the total award are permitted.

Translational projects should move a novel strategy from the laboratory into a human clinical trial or use specimens from a clinical trial to develop biomarkers or mechanisms. The research should apply in some direct way to human beings within the time frame of less than three years. If biomarker research is undertaken, a validation set or independent clinical trial is essential. A plan for biomarker validation, if applicable, must be included in any proposal. The endpoint of the project should be the planning or initiation of a new clinical trial.